Publications by authors named "R J SCHNITZER"

Oncogenic alterations in human epidermal growth factor receptor 2 (HER2) occur in approximately 2% of patients with non-small cell lung cancer and predominantly affect the tyrosine kinase domain and cluster in exon 20 of the ERBB2 gene. Most clinical-grade tyrosine kinase inhibitors are limited by either insufficient selectivity against wild-type (WT) epidermal growth factor receptor (EGFR), which is a major cause of dose-limiting toxicity or by potency against HER2 exon 20 mutant variants. Here we report the discovery of covalent tyrosine kinase inhibitors that potently inhibit HER2 exon 20 mutants while sparing WT EGFR, which reduce tumor cell survival and proliferation in vitro and result in regressions in preclinical xenograft models of HER2 exon 20 mutant non-small cell lung cancer, concomitant with inhibition of downstream HER2 signaling.

View Article and Find Full Text PDF

The properties of the heat-affected zone (HAZ) are reported to have a great influence on the mechanical performance of resistance spot welded advanced high strength steels. Therefore, in the present work, the HAZ of a medium-Mn steel is characterized regarding its microstructure and its mechanical properties depending on the distance to the fusion zone (FZ). In order to obtain the local mechanical properties of the HAZ, samples were heat-treated in a joule-heating thermal simulator using different peak temperatures to physically simulate the microstructure of the HAZ.

View Article and Find Full Text PDF
Article Synopsis
  • KRAS is a key oncogenic driver in cancers and relies on protein-protein interactions (PPIs) for its signaling, especially with SOS1 for activation.
  • A study found that adding just one atom between specific residues in SOS1 can turn the SOS1 activators into inhibitors.
  • This new method, which utilizes small modifications rather than large molecules, shows promise in inhibiting challenging PPIs like SOS1-KRAS, especially when combined with the EGFR inhibitor afatinib to target KRAS mutant colorectal tumors.
View Article and Find Full Text PDF

Natural killer (NK) cells play a pivotal role in controlling cancer. Multiple extracellular receptors and internal signaling nodes tightly regulate NK activation. Cyclin-dependent kinases of the mediator complex (CDK8 and CDK19) were described as a signaling intermediates in NK cells.

View Article and Find Full Text PDF